Role of HER receptors family in development and differentiation
Open Access
- 23 January 2004
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 200 (3) , 343-350
- https://doi.org/10.1002/jcp.20007
Abstract
Members of the epidermal growth factor receptor family of receptor tyrosine kinases play a critical role in both development and oncogenesis. The latter is suggested by the frequent overexpression of HER‐2, EGFR, and HER‐3 in some human carcinomas, primarily breast and squamous cancer. The biological activities of the EGFR family are exerted through various ligand–receptor and receptor–receptor interactions. One receptor that plays a central role in this signaling network is HER‐2/Neu, which is considered the preferred heterodimerization partner for other members of the EGFR family. The role of these receptors and their ligands in development is discussed, with particular emphasis on their ability to mediate a variety of pathways and cellular responses, including proliferation, differentiation, and apoptosis.Keywords
Funding Information
- AIRC
This publication has 71 references indexed in Scilit:
- Impaired differentiation and lactational failure ofErbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5Development, 2003
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- EGF receptor: which way to go?FEBS Letters, 2001
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cellsOncogene, 2000
- Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactationOncogene, 1999
- Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinaseOncogene, 1999
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- EGF Receptor and erb B-2 Tyrosine Kinase Domains Confer Cell Specificity for Mitogenic SignalingScience, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987